$60.38
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
ANI Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ANI Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $1.02 | $0.94 | 8.51 % |
Mar 2024 | 2024-05-10 | $1.21 | $0.99 | 22.2 % |
Dec 2023 | 2024-02-29 | $1.00 | $0.85 | 17.6 % |
Sep 2023 | 2023-11-08 | $1.27 | $0.84 | 51.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $138.04M | $128.62M | 7.32 % |
Mar 2024 | 2024-05-10 | $137.43M | $125.52M | 9.49 % |
Dec 2023 | 2024-02-29 | $131.65M | $122.21M | 7.73 % |
Sep 2023 | 2023-11-08 | $131.83M | $111.92M | 17.8 % |
ANI Pharmaceuticals (ANIP) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $1.02, which beat the estimate of $0.94.
The Actual Revenue was $138M, which beat the estimate of $128.6M.
Browse earnings estimates, EPS, and revenue on all stocks.